Progesterone
Actions of progesterone include all of the following except :
| A |
Increase the tone of cervical sphincter |
|
| B |
Reduces the tone of uterine contractions |
|
| C |
Sodium and water retention |
|
| D |
Secretory hypertrophy |
Actions of progesterone include all of the following except :
| A |
Increase the tone of cervical sphincter |
|
| B |
Reduces the tone of uterine contractions |
|
| C |
Sodium and water retention |
|
| D |
Secretory hypertrophy |
Reduces the tone of uterine contractions
Progesterone is produced by
| A |
Granulosa luteal cells |
|
| B |
Stroma ot the ovary |
|
| C |
Theca cells |
|
| D |
Sertoli cells |
Progesterone is produced by
| A |
Granulosa luteal cells |
|
| B |
Stroma ot the ovary |
|
| C |
Theca cells |
|
| D |
Sertoli cells |
Granulosa luteal cells
A patient with amenorrhea had bleeding after giving a trial of progesterone. This implies :
| A |
Sufficient estrogen |
|
| B |
Intact pituitary axis |
|
| C |
Normal ovarian function and Intact endometrium both |
|
| D |
All |
A patient with amenorrhea had bleeding after giving a trial of progesterone. This implies :
| A |
Sufficient estrogen |
|
| B |
Intact pituitary axis |
|
| C |
Normal ovarian function and Intact endometrium both |
|
| D |
All |
Ans. is a, b and c i.e. Sufficient estrogen; Normal ovarian function; Intact endometrium; and Intact pituitary axis
Note : Friends it is quite difficult to understand the above chart in one go, you will have to go through it 3 – 4 times to understand it well.
Also revise the various compartments of menstruation from Q.No. 3 for better and complete understanding.
Positive progesterone challenge test in a patient of secondary amenorrhoea, seen in :
| A |
Asherman Syndrome |
|
| B |
Endometrial TB |
|
| C |
Hypopituitarism |
|
| D |
PCOD |
Positive progesterone challenge test in a patient of secondary amenorrhoea, seen in :
| A |
Asherman Syndrome |
|
| B |
Endometrial TB |
|
| C |
Hypopituitarism |
|
| D |
PCOD |
Ans. is d i.e. PCOD
If a patient is having positive progesterone challenge test it means
Uterus is sufficiently primed with estrogen i.e. estrogen production is normal so, hypopituitarism (option “c”)
Uterus with its endometrial lining is normal i.e. Ashermann syndrome (option “a”)and Endometrial TB (option “b”) ruled out.
Outflow tract is normal.
The defect lies in production of progesterone (as when progesterone is supplemented from outside it results in withdrawl bleeding) and since progesterone is produced mainly by corpus luteum so, the defect is anovulation. The main cause of Anovulation in a case of 2° amenorrhea is polycystic ovarian disease (option “d”)
Withdrawal bleeding with progesterone seen in otherwise amenorrhoeic woman due to :
| A |
Hypogonadotrophic hypogonadism |
|
| B |
Anovulation |
|
| C |
Ovarian failure |
|
| D |
TB endometritis |
Withdrawal bleeding with progesterone seen in otherwise amenorrhoeic woman due to :
| A |
Hypogonadotrophic hypogonadism |
|
| B |
Anovulation |
|
| C |
Ovarian failure |
|
| D |
TB endometritis |
Ans. is b i.e. Anovulation
Simple hyperplasia of the endometrium treated with progesterone for— days :
| A |
14 |
|
| B |
21 |
|
| C |
5 |
|
| D |
10 |
Simple hyperplasia of the endometrium treated with progesterone for— days :
| A |
14 |
|
| B |
21 |
|
| C |
5 |
|
| D |
10 |
21
The progesterone of choice for emergency contraception is :
| A |
Norethisterone |
|
| B |
Medroxyprogesteroneacetate |
|
| C |
Levonorgesterel |
|
| D |
Desogestrel |
The progesterone of choice for emergency contraception is :
| A |
Norethisterone |
|
| B |
Medroxyprogesteroneacetate |
|
| C |
Levonorgesterel |
|
| D |
Desogestrel |
Ans. is c i.e. Levonergesterol
The progeserone of choice for emergency contraception is Levonorgesterel. Dose of Levonergesterol for emergency contraception= 0.75mg
Adavntages
- It has no estrogenic side effects
- Can be given to hypertensive, cardiac and diabetic women.
- Can be given to lactating women
Single dose therapy (i.e. 2 tablets taken as a single dose) can be given. It is contraindicated in women with H/O thrombophelebitis and migraine.
In a woman on subdermal progesterone implant, the menstrual abnormality seen is :
| A |
Menorrhagia |
|
| B |
Metrorrhagia |
|
| C |
Polymenorrhoea |
|
| D |
Amenorrhoea |
In a woman on subdermal progesterone implant, the menstrual abnormality seen is :
| A |
Menorrhagia |
|
| B |
Metrorrhagia |
|
| C |
Polymenorrhoea |
|
| D |
Amenorrhoea |
Ans. is b i.e. Metrorrhagia
Depot medroxyprogesterone acetate is sparingly used as a contraceptive because it causes :
| A |
Cardio vascular complications |
|
| B |
Lactational failure |
|
| C |
Breast cancer |
|
| D |
Irregular menstrual bleeding |
Depot medroxyprogesterone acetate is sparingly used as a contraceptive because it causes :
| A |
Cardio vascular complications |
|
| B |
Lactational failure |
|
| C |
Breast cancer |
|
| D |
Irregular menstrual bleeding |
Irregular menstrual bleeding
All of the following are features of progesterone pills except :
| A |
Acts by altering cervical mucous secretion |
|
| B |
Break ovulation cycle |
|
| C |
Failure rate is equal to that seen with OCP’s |
|
| D |
Irregular bleeding is a known complications |
All of the following are features of progesterone pills except :
| A |
Acts by altering cervical mucous secretion |
|
| B |
Break ovulation cycle |
|
| C |
Failure rate is equal to that seen with OCP’s |
|
| D |
Irregular bleeding is a known complications |
Failure rate is equal to that seen with OCP’s
Oral contraceptive pill containing progesterone which is given in small quantities for 30 days a month is known as :
| A |
Micro pill |
|
| B |
Sequential pill |
|
| C |
Combined pill |
|
| D |
None of the aboveq |
Oral contraceptive pill containing progesterone which is given in small quantities for 30 days a month is known as :
| A |
Micro pill |
|
| B |
Sequential pill |
|
| C |
Combined pill |
|
| D |
None of the aboveq |
Micro pill
The low Dose progesterone — only type of oral contraceptive acts by :
| A |
Inhibition of the midcycle surge of leteinizing hormone |
|
| B |
Rendering cervical mucus less penetrable by sperm |
|
| C |
Preventing ovulation |
|
| D |
b and c |
The low Dose progesterone — only type of oral contraceptive acts by :
| A |
Inhibition of the midcycle surge of leteinizing hormone |
|
| B |
Rendering cervical mucus less penetrable by sperm |
|
| C |
Preventing ovulation |
|
| D |
b and c |
b and c
Sourse of progesterone during normal mestrual cycle :
| A |
Corpus luteum |
|
| B |
Stroma |
|
| C |
Surface epithelium of ovary |
|
| D |
None |
Sourse of progesterone during normal mestrual cycle :
| A |
Corpus luteum |
|
| B |
Stroma |
|
| C |
Surface epithelium of ovary |
|
| D |
None |
Corpus luteum
Progesterone of choice in emergency contraception is
| A |
Norethisterone |
|
| B |
Medroxy progesterone |
|
| C |
Desogestrel |
|
| D |
Levonorgestrel |
Progesterone of choice in emergency contraception is
| A |
Norethisterone |
|
| B |
Medroxy progesterone |
|
| C |
Desogestrel |
|
| D |
Levonorgestrel |
Levonorgestrel [Ref: Novak’s Gynaecology I4/e, p 283-285; Hormones in Obstetrics and Gynaecology by V. Zutshi 2/e, p 142-150; Fertility Control by Chaudhuri 6/e, p 190-197; Dutta Obstetrics 6/e, p 549550]
Levonorgestrel alone, 0.75 mg stat F/B another 0.75 mg 12 hrs later, taken within 72 hrs of unprotected intercourse is the method of choice .for emergency contraception
- Emergency contraception is also k/a postcoital morning after contraception. Basically the methods used interfere with the physiological events before implantation, for e.g. inhibition or delaying of ovulation or interference with postovulatory events necessary for implantation & longevity of the blastocyst.
- Agents used for emergency contraception are known as ‘interceptives’.
|
Methods of emergency contraception |
|||
|
Drugs |
Dosage |
Time frame |
Preg. rate |
|
• High dose estrogens (not used now) |
|
|
|
|
– Ethinyl estradiol (EE) |
2.5 mg BD x 5 days |
Within 72 hrs of coitus |
L-0.15% |
|
– Conjugated equine estrogen (CEE) |
15 mg BD x 5 days |
|
0-0.6% |
|
• Estrogen & progestin combination pill |
|
„ |
|
|
– Yuzpe method EE 50 rg + d, l-NG 0.5 mg (Ovral) |
2 tabs stat & 2 tabs after 12 hrs |
,, ,, |
0-2% |
|
|
(Total dose EE 0.2 mg & LNG 2 mg) |
|
|
|
– Low dose pills |
|
,, II |
0-2% |
|
EE 30 lig + LNG 0.15mg (Ovral L, Mala-N etc.) |
4 tabs stat & 4 tabs after 12 hors |
|
|
|
• Levonorgestrel (LNG) alone (Ecee 2, i- |
0.75 mg stat F/B |
Preferably |
0-1% |
|
pill, E-pill, unwanted-72, Plan-B) |
0.75 mg after 12 hrs or 1.5 mg stat |
within 72 hrs but can be given upto 5 days |
|
|
• Centchroman 30mg |
2 tab BD x 1 day |
Within 5 days |
not known |
|
(Saheli) |
|
|
|
|
• Danazol |
400/800 mg BD x |
Within 72 hrs |
0.8 – 1.7% |
|
|
3 days or |
|
|
|
|
1200 mg BD x 2 days |
|
|
|
• Mifepristone (RU 486) |
600 mg/200 mg / |
Within 5 days to |
– 1.3% |
|
|
10 mg single dose |
27th day of cycle |
|
|
• Copper IUD (more effective than steroids) |
To be inserted within 7 days |
|
< 1% |
Progesterone of choice in emergency contraception is?
| A |
Norethisterone |
|
| B |
Medroxyprogesterone |
|
| C |
Oxytocin |
|
| D |
Levonorgestrel |
Progesterone of choice in emergency contraception is?
| A |
Norethisterone |
|
| B |
Medroxyprogesterone |
|
| C |
Oxytocin |
|
| D |
Levonorgestrel |
Unprotected intercourse without regard to the time of the month carries an 8% incidence of pregnancy, an incidence that can be reduced to 2% by the use of emergency contraceptives within 72 hours of unprotected intercourse.
Which of the following is indication for using endogenous progesterone?
| A |
Contraception |
|
| B |
For diagnostic of secondary amenorrhea |
|
| C |
Endometrial hyperplasia |
|
| D |
All of the above |
Which of the following is indication for using endogenous progesterone?
| A |
Contraception |
|
| B |
For diagnostic of secondary amenorrhea |
|
| C |
Endometrial hyperplasia |
|
| D |
All of the above |
Which of the following progesterones is preferred in combination with estrogen in low dose oral contraceptive pills?
| A |
Desogesterol |
|
| B |
Norethisterone |
|
| C |
Norgesterel |
|
| D |
Levonorgestrel |
Which of the following progesterones is preferred in combination with estrogen in low dose oral contraceptive pills?
| A |
Desogesterol |
|
| B |
Norethisterone |
|
| C |
Norgesterel |
|
| D |
Levonorgestrel |
| A |
Lactation |
|
| B |
Ovulation |
|
| C |
Secretory endometrium |
|
| D |
Vaginal cornification index |
| A |
Lactation |
|
| B |
Ovulation |
|
| C |
Secretory endometrium |
|
| D |
Vaginal cornification index |
What is the effect of progesterone on lipids normally?
| A |
Lowers LDL, increases HDL |
|
| B |
Lowers HDL and LDL |
|
| C |
Lowers HDL and increases LDL |
|
| D |
Increases LDL and HDL |
What is the effect of progesterone on lipids normally?
| A |
Lowers LDL, increases HDL |
|
| B |
Lowers HDL and LDL |
|
| C |
Lowers HDL and increases LDL |
|
| D |
Increases LDL and HDL |
All of the following are metabolic effects of progesterone in normal pregnancy, EXCEPT:
| A |
It increases basal insulin levels |
|
| B |
Norgestrel increase glucose tolerance |
|
| C |
Stimulates lipoprotein lipase activity |
|
| D |
Does not alter glucose tolerance |
All of the following are metabolic effects of progesterone in normal pregnancy, EXCEPT:
| A |
It increases basal insulin levels |
|
| B |
Norgestrel increase glucose tolerance |
|
| C |
Stimulates lipoprotein lipase activity |
|
| D |
Does not alter glucose tolerance |
Progesterone of choice in emergency contraception is the following:
| A |
DMPA |
|
| B |
Levonorgestrel |
|
| C |
Norgestrel |
|
| D |
Micronised progesterone |
Progesterone of choice in emergency contraception is the following:
| A |
DMPA |
|
| B |
Levonorgestrel |
|
| C |
Norgestrel |
|
| D |
Micronised progesterone |
- Estrogen-progestin Combinations
- Antiprogestins and selective progestin-receptor modulators
- Copper-containing intrauterine devices within 5 days after unprotected intercourse
A 26 weeks pregnant primigravida comes to the casualty with an acute attack of breatlessness.
| A |
Both Assertion and Reason are true, and Reason is the correct explanation for Assertion |
|
| B |
Both Assertion and Reason are true, and Reason is not the correct explanation for Assertion |
|
| C |
Assertion is true, but Reason is false |
|
| D |
Assertion is false, but Reason is true |
A 26 weeks pregnant primigravida comes to the casualty with an acute attack of breatlessness.
| A |
Both Assertion and Reason are true, and Reason is the correct explanation for Assertion |
|
| B |
Both Assertion and Reason are true, and Reason is not the correct explanation for Assertion |
|
| C |
Assertion is true, but Reason is false |
|
| D |
Assertion is false, but Reason is true |
The course of the asthma in pregnancy is unpredictable.
In about 20%, the condition improves, in 30%, it deteriorates and in 50%, it remains unchanged.
Ref: Textbook of Obstetrics by D. C. Dutta, 6th Edition, Page 302
All of the statements regarding progesterone only pill are true, except
| A |
Inhibits ovulation |
|
| B |
Failure rate is the same as combined OCP |
|
| C |
Irregular bleeding is a known complication |
|
| D |
Acts by altering the cervical mucous |
All of the statements regarding progesterone only pill are true, except
| A |
Inhibits ovulation |
|
| B |
Failure rate is the same as combined OCP |
|
| C |
Irregular bleeding is a known complication |
|
| D |
Acts by altering the cervical mucous |
Failure rate of combined OCP is 0.2/100 women years, whereas failure rate of progesterone only pill is about 0.5 – 2 per 100 women years of use.
Progesterone only pill acts by thickening cervical mucous, causing atrophy of endometrium or by inhibiting ovulation.
The breast is a hormonally responsive organ. Which statement about progesterone is NOT true?
| A |
Progesterone is produced in the ovary |
|
| B |
Progesterone stimulates growth of the lobules and the acini |
|
| C |
Progesterone causes an increase in interstitial fluid in the breast |
|
| D |
Progesterone promotes growth of both the stroma and the duct system of the breast |
The breast is a hormonally responsive organ. Which statement about progesterone is NOT true?
| A |
Progesterone is produced in the ovary |
|
| B |
Progesterone stimulates growth of the lobules and the acini |
|
| C |
Progesterone causes an increase in interstitial fluid in the breast |
|
| D |
Progesterone promotes growth of both the stroma and the duct system of the breast |
Which of the following acts as transporting protein for progesterone?
| A |
Sex hormone binding protein |
|
| B |
Transcortin |
|
| C |
Albumin |
|
| D |
None of the above |
Which of the following acts as transporting protein for progesterone?
| A |
Sex hormone binding protein |
|
| B |
Transcortin |
|
| C |
Albumin |
|
| D |
None of the above |
Which of the following is a selective progesterone receptor modulator-
| A |
Onapristone |
|
| B |
Ulipristal |
|
| C |
Nomegestrol |
|
| D |
Toremifene |
Which of the following is a selective progesterone receptor modulator-
| A |
Onapristone |
|
| B |
Ulipristal |
|
| C |
Nomegestrol |
|
| D |
Toremifene |
Ans. is ‘b’ i.e., Ulipristal
o Ulipristal is a SPRM approved for use as an Emergency Contraceptive.
o SPRM (selective progesterone receptor modulators) : Asoprisnil, ul ipristal, onapristone, mifepristone.
Disadvantage of depomedroxy progesterone acetate [DMPA]:
March 2011
| A |
Weight gain |
|
| B |
Increased chances of menorrhagia |
|
| C |
Irregular bleeding and prolonged anovulation |
|
| D |
A and C both |
Disadvantage of depomedroxy progesterone acetate [DMPA]:
March 2011
| A |
Weight gain |
|
| B |
Increased chances of menorrhagia |
|
| C |
Irregular bleeding and prolonged anovulation |
|
| D |
A and C both |
Ans. C > A: Irregular bleeding and prolonged anovulation > Weight gain
Menstrual irregularity occurs and amenorrhea is reported in 20-50 % at the end of 1 year, more with DMPA than NETO (norethisterone acetate). Heavy bleeding is reported in 1-2% of users
There is return in return of fertility but 80% are expected to conceive by end of 1 year. With DMPA, ovulation returns in 5 months, and with NETO, within 3 months of the last injection
The side effects of weight gain, depression, bloated feeling and mastalgia can occur with the injectable progestigen
Most common metabolite of progesterone excreted in urine is _________
| A |
Pregnanelone |
|
| B |
Pregnanetriol |
|
| C |
17-hydroxy pregnanolone |
|
| D |
Pregnanediol |
Most common metabolite of progesterone excreted in urine is _________
| A |
Pregnanelone |
|
| B |
Pregnanetriol |
|
| C |
17-hydroxy pregnanolone |
|
| D |
Pregnanediol |
Pregnanediol is an inactive metabolic product of progesterone. A test can be done to measure the amount of pregnanediol in urine, which offers an indirect way to measure progesterone levels in the body.
The principal pathway of the metabolism of progesterone is believed to be progesterone → pregnanedione → pregnanolone → pregnanediol, although small amounts of the corresponding allopregnane compounds are formed.
Action of progesterone ‑
| A |
Increased sensitivity of uterus to oxytocin |
|
| B |
Inhibits LH secretion |
|
| C |
Decrease in body temperature |
|
| D |
Causes proliferative changes in uterus |
Action of progesterone ‑
| A |
Increased sensitivity of uterus to oxytocin |
|
| B |
Inhibits LH secretion |
|
| C |
Decrease in body temperature |
|
| D |
Causes proliferative changes in uterus |
Ans. is ‘b’ i.e., Inhibits LH secretion
At puberty true is ‑
| A |
Decreased FSH and LH |
|
| B |
Decreased GnRH |
|
| C |
Increased progesterone |
|
| D |
Decreased estrogen |
At puberty true is ‑
| A |
Decreased FSH and LH |
|
| B |
Decreased GnRH |
|
| C |
Increased progesterone |
|
| D |
Decreased estrogen |
Ans. is ‘c’ i.e., Increased progesterone
Puberty is triggered by a release of gonadotropins (FSH and LH) from pituitary gland.
These hormones act as signals to the gonads (testes/ovaries) that trigger the production of –
i) Estrogen, progesterone and some testosterone in women.
ii) Testosterone in men.
Leptin facilitates release of gonadotropin releasing hormone (GnRH), thereby helping in pubertal onset.
Red keratic precipitates are seen in ‑
| A |
Granulomatous uveits |
|
| B |
Hemorrhagic uveitis |
|
| C |
Old healed uveitis |
|
| D |
Acute anterior uveitis |
Red keratic precipitates are seen in ‑
| A |
Granulomatous uveits |
|
| B |
Hemorrhagic uveitis |
|
| C |
Old healed uveitis |
|
| D |
Acute anterior uveitis |
Ans. is .b i.e., Hemorrhagic uveitis
Keratic precipitates (KPs)
- KPs are proteinaceous cellular deposits occurring at the back of cornea (corneal endothelial deposits). Keratic precipitates are formed by the aggregation of polymorphonuclear cells, lymphocytes, and epitheloid cells. In the setting of uveitis, the bimicrosopic appearance of KP may yeild important diagnostic clues for the identification of the underlying inflammatory disorder :‑
Mutton fat KP :- Large, yellowish KPs, are characteristic ofgranulomatous uveitis. These are composed of epitheloid cells and macrophages. They are large, thick fluffy, lardaceous KPs, having a greasy or waxy appearance.
Small or medium KPs (granular KPs):- These are composed of lymphocytes and are characteristic of non- granulomatous uveitis. These are small, round and whitish precipitates
Red KPs :- Composed of RBCs and inflammatory cells. These are seen in hemorrhagic uveitis.
Old KPs :- In healed uveitis. The above described KPs shrink, fade, become pigmented and irregular in shape with crenated margins.
Which drug can be given subdermally ‑
| A |
Nicotine |
|
| B |
Fentanyl |
|
| C |
GTN |
|
| D |
Progesterone |
Which drug can be given subdermally ‑
| A |
Nicotine |
|
| B |
Fentanyl |
|
| C |
GTN |
|
| D |
Progesterone |
Ans. is ‘d’ i.e., Progesterone
- Progesterone can be given in the form of subdermal implant.
- Subdermal contraceptive implants involve the delivery of a steroid progestin from polymer capsules or rods placed under the skin.
- The hormone diffuses out slowly at a stable rate, providing contraceptive effectiveness for 1-5 years.
- The period of protection depends upon the specific progestin and the type of polymer.
- Advantages of progestin implants include long term contraceptive action without requiring the user’s or provider’s attention, low dose of highly effective contraception without the use of estrogen, and fertility is readily reversible after the removal of implants.
- The levonorgestrel implant Norplant R system is the only one that has been approved for distribution.
- The contraceptive efficacy of Norplant is the highest observed amongst the most effective methods with an annual pregnancy rate of 0.2 during the first and second year and 1 1 on the fifth year. Menstrual problems are the main reason for the discontinuation of Norplant and 9% of women stopped using it during the first year of treatment.



